Ocriplasmin for symptomatic vitreomacular adhesion
BlueCross BlueShield Association
Record ID 32013000684
English
Authors' objectives:
To determine whether intraocular injection of ocriplasmin improves health outcomes compared to standard treatment.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.bcbs.com/blueresources/tec/vols/28/28_05.pdf
URL for additional information:
http://www.bcbs.com/blueresources/tec/vols/28/ocriplasmin-for-symptomatic.html
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Fibrinolysin
- Peptide Fragments
- Eye Diseases
- Tissue Adhesions
- Vitreous Body
Contact
Organisation Name:
BlueCross BlueShield Association
Contact Address:
BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
tec@bcbsa.com
Contact Email:
tec@bcbsa.com
Copyright:
BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.